Header

UZH-Logo

Maintenance Infos

Publications for Elzi, L

Navigate back| Up a level
Export as
Group by:
Number of items: 40.

2017

Elzi, Luigia; Erb, Stefan; Furrer, Hansjakob; Cavassini, Matthias; Calmy, Alexandra; Vernazza, Pietro; Günthard, Huldrych; Bernasconi, Enos; Battegay, Manuel; Swiss HIV Cohort Study (2017). Adverse events of raltegravir and dolutegravir. AIDS, 31(13):1853-1858.

2016

Stuehler, Claudia; Bernardini, Claudia; Elzi, Luigia; Stoeckle, Marcel; Zimmerli, Stefan; Furrer, Hansjakob; Günthard, Huldrych F; Leibundgut-Landmann, Salomé; Battegay, Manuel; Khanna, Nina (2016). Immune recovery in HIV-infected patients after Candida esophagitis is impaired despite long-term antiretroviral therapy. AIDS, 30(12):1923-1933.

Elzi, Luigia; Conen, Anna; Patzen, Annalea; Fehr, Jan; Cavassini, Matthias; Calmy, Alexandra; Schmid, Patrick; Bernasconi, Enos; Furrer, Hansjakob; Battegay, Manuel (2016). Ability to work and employment rates in human immunodeficiency virus (HIV)-1-infected individuals receiving combination antiretroviral therapy: The Swiss HIV cohort study. Open Forum Infectious Diseases, 3(1):ofw022.

2015

Hollenstein, Y; Elzi, L; Hatz, Christoph; Passweg, J; Weisser, M; Stoeckle, M; Halter, J; Egli, A (2015). Travelling activity and travel-related risks after allogeneic haematopoietic stem cell transplantation – a single centre survey. Swiss Medical Weekly, 145:w14136.

2014

Battegay, Manuel; Haerry, David Hans-U; Fehr, Jan; Staehelin, Cornelia; Wandeler, Gilles; Elzi, Luigia (2014). Psychosoziale Aspekte bei der Behandlung der HIV-Infektion. Therapeutische Umschau. Revue thérapeutique, 71(8):509-513.

Staehelin, Cornelia; Elzi, Luigia; Weber, Rainer; Furrer, Hansjakob (2014). Therapie und Prävention von opportunistischen Infektionen. Therapeutische Umschau. Revue thérapeutique, 71(8):475-482.

2013

Nüesch, Reto; Wang, Qing; Elzi, Luigia; Bernasconi, Enos; Weber, Rainer; Cavassini, Matthias; Vernazza, Pietro; Thurnheer, Maria C; Calmy, Alexandra; Battegay, Manuel; Bucher, Heiner C (2013). Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS). Journal of Acquired Immune Deficiency Syndromes, 62(4):396-404.

Boillat-Blanco, Noémie; Darling, Katharine E A; Taffe, Patrick; Osih, Regina; Strahm, Carol; Adami, Maddalena; Elzi, Luigia; Daou, Samira; Fehr, Jan; Wandeler, Gilles; Cavassini, Matthias (2013). Impact of recommendation updates in well-controlled patients on non-recommended antiretroviral therapies: the Swiss HIV Cohort Study. Journal of Acquired Immune Deficiency Syndromes, 62(2):180-189.

2012

Elzi, Luigia; Erb, Stefan; Furrer, Hansjakob; Ledergerber, Bruno; Cavassini, Matthias; Hirschel, Bernard; Vernazza, Pietro; Bernasconi, Enos; Weber, Rainer; Battegay, Manuel (2012). Choice of initial combination antiretroviral therapy in individuals with hiv infection: determinants and outcomes. Archives of internal medicine, 172(17):1313-1321.

Scherrer, Alexandra U; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Aubert, Vincent; Furrer, Hansjakob; Calmy, Alexandra; Cavassini, Matthias; Elzi, Luigia; Vernazza, Pietro L; Bernasconi, Enos; Ledergerber, Bruno; Günthard, Huldrych F (2012). Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens. PLoS ONE, 7(11):e50307.

Staehelin, C; Keiser, O; Calmy, A; Weber, R; Elzi, L; Cavassini, M; Schmid, P; Bernasconi, E; Furrer, H (2012). Longer term clinical and virological outcome of Sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study. Journal of Acquired Immune Deficiency Syndromes, 59(1):79-85.

Scherrer, Alexandra U; Ledergerber, Bruno; von Wyl, Viktor; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Cellerai, Cristina; Furrer, Hansjakob; Calmy, Alexandra; Cavassini, Matthias; Elzi, Luigia; Vernazza, Pietro L; Bernasconi, Enos; Günthard, Huldrych F (2012). Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients. PLoS ONE, 7(6):e37983.

Thierfelder, C; Weber, R; Elzi, L; Furrer, H; Cavassini, M; Calmy, A; Bernasconi, E; Gutmann, C; Ledergerber, B (2012). Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study. HIV Medicine, 13(2):118-126.

2011

Marzolini, C; Back, D; Weber, R; Furrer, H; Cavassini, M; Calmy, A; Vernazza, P; Bernasconi, E; Khoo, S; Battegay, M; Elzi, L (2011). Ageing with HIV: medication use and risk for potential drug-drug interactions. Journal of Antimicrobial Chemotherapy, 66(9):2107-2111.

Lubomirov, R; Colombo, S; di Iulio, J; Ledergerber, B; Martinez, R; Cavassini, M; Hirschel, B; Bernasconi, E; Elzi, L; Vernazza, P; Furrer, H; Günthard, H F; Telenti, A (2011). Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort study. Journal of Infectious Diseases, 203(2):246-257.

Kenfak-Foguena, A; Schöni-Affolter, F; Bürgisser, P; Witteck, A; Darling, K E A; Kovari, H; Kaiser, L; Evison, J M; Elzi, L; Gurter-De La Fuente, V; Jost, J; Moradpour, D; Abravanel, F; Izpopet, J; Cavassini, M (2011). Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerging Infectious Diseases, 17(6):1074-8.

Boillat-Blanco, Noémie; Probst, A; Da Costa, V W; Giulieri, S; Bernasconi, E; Calmy, A; Elzi, L; Rauch, A; Weber, R; Bertisch, B; Cavassini, M; Bochud, P Y (2011). Impact of a nurse vaccination program on hepatitis B immunity in a Swiss HIV clinic. Journal of Acquired Immune Deficiency Syndromes, 58(5):472-474.

Mossdorf, E; Stoeckle, M; Mwaigomole, E G; Chiweka, E; Kibatala, P L; Geubbels, E; Urassa, H; Abdulla, S; Elzi, L; Tanner, M; Furrer, H; Hatz, C; Battegay, M (2011). Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition. BMC Infectious Diseases, 11:98.

Elzi, L; Steffen, I; Furrer, H; Fehr, J; Cavassini, M; Hirschel, B; Hoffmann, M; Bernasconi, E; Bassetti, S; Battegay, M (2011). Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection. BMC Infectious Diseases, 11:319.

Scherrer, A U; Ledergerber, B; von Wyl, V; Böni, J; Yerly, S; Klimkait, T; Bürgisser, P; Rauch, A; Hirschel, B; Cavassini, M; Elzi, L; Vernazza, P L; Bernasconi, E; Held, L; Günthard, H F (2011). Improved virological outcome in white patients infected with HIV-1 non-B subtypes compared to subtype B. Clinical Infectious Diseases, 53(11):1143-1152.

Kaufmann, G R; Elzi, L; Weber, R; Furrer, H; Giulieri, S; Vernazza, P; Bernasconi, E; Hirschel, B; Battegay, M (2011). Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death. AIDS, 25(4):441-451.

Ortiz, M; Poloni, E S; Furrer, H; Kovari, H; Martinez, R; Arnedo, M; Elzi, L; Bernasconi, E; Vernazza, P; Hirschel, B; Cavassini, M; Ledergerber, B; Günthard, H F; Telenti, A; Tarr, P E (2011). No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy. Journal of Infectious Diseases, 203(5):620-624.

2010

Franceschi, S; Lise, M; Clifford, G M; Rickenbach, M; Levi, F; Maspoli, M; Bouchardy, C; Dehler, S; Jundt, G; Ess, S; Bordoni, A; Konzelmann, I; Frick, H; Dal Maso, L; Elzi, L; Furrer, H; Calmy, A; Cavassini, M; Ledergerber, B; Keiser, O; Swiss HIV Cohort Study (2010). Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. British Journal of Cancer, 103(3):416-422.

Hasse, B; Ledergerber, B; Hirschel, B; Vernazza, P; Glass, T R; Jeannin, A; Evison, J M; Elzi, L; Cavassini, M; Bernasconi, E; Nicca, D; Weber, R (2010). Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study. Clinical Infectious Diseases, 51(11):1314-1322.

Mueller, N J; Fux, C A; Ledergerber, B; Elzi, L; Schmid, P; Dang, T; Magenta, L; Calmy, A; Vergopoulos, A; Bischoff-Ferrari, H A (2010). High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. AIDS, 24(8):1127-1134.

Mossdorf, E; Stoeckle, M; Vincenz, A; Mwaigomole, E G; Chiweka, E; Kibatala, P; Urassa, H; Abdulla, S; Elzi, L; Tanner, M; Furrer, H; Hatz, C; Battegay, M (2010). Impact of a national HIV voluntary counselling and testing (VCT) campaign on VCT in a rural hospital in Tanzania. Tropical Medicine & International Health, 15(5):567-573.

Rotger, M; Gsponer, T; Martinez, R; Taffé, P; Elzi, L; Vernazza, P; Cavassini, M; Bernasconi, E; Hirschel, B; Furrer, H; Weber, R; Ledergerber, B; Egger, M; Telenti, A; Tarr, P E; Swiss HIV Cohort Study (2010). Impact of single nucleotide polymorphisms and of clinical risk factors on new‐onset diabetes mellitus in HIV‐infected individuals. Clinical Infectious Diseases, 51(9):1090-1098.

Ferry, T; Hirschel, B; Dang, T; Meylan, P; Delhumeau, C; Rauch, A; Weber, R; Elzi, L; Bernasconi, E; Schmid, P; Calmy, A (2010). Infrequent replication of parvovirus B19 and erythrovirus genotypes 2 and 3 among HIV-infected patients with chronic anemia. Clinical Infectious Diseases, 50(1):115-118.

Thurnheer, M C; Weber, R; Toutous-Trellu, L; Cavassini, M; Elzi, L; Schmid, P; Bernasconi, E; Christen, A B; Zwahlen, M; Furrer, H (2010). Occurrence, risk factors, diagnosis and treatment of syphilis in the prospective observational Swiss HIV cohort study. AIDS, 24(12):1907-1916.

Osih, R B; Taffé, P; Rickenbach, M; Gayet-Ageron, A; Elzi, L; Fux, C; Opravil, M; Bernasconi, E; Schmid, P; Günthard, H F; Cavassini, M (2010). Outcomes of patients on dual-boosted PI regimens: experience of the Swiss HIV cohort study. AIDS Research and Human Retroviruses, 26(11):1239-1246.

Marzolini, C; Elzi, L; Gibbons, S; Weber, R; Fux, C; Furrer, H; Chave, J P; Cavassini, M; Bernasconi, E; Calmy, A; Vernazza, P; Khoo, S; Ledergerber, B; Back, D; Battegay, M (2010). Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study. Antiviral Therapy, 15(3):413-423.

Elzi, L; Marzolini, C; Furrer, H; Ledergerber, B; Cavassini, M; Hirschel, B; Vernazza, P; Bernasconi, E; Weber, R; Battegay, M (2010). Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008. Archives of Internal Medicine, 170(1):57-65.

2009

Elzi, L; Kaufmann, G; Weber, R; Fux, C A; Cavassini, M; Hirschel, B; Vernazza, P; Bernasconi, E; Battegay, M (2009). Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals. HIV Clinical Trials, 10(4):207-214.

Khanna, N; Elzi, L; Mueller, N J; Garzoni, C; Cavassini, M; Fux, C A; Vernazza, P; Bernasconi, E; Battegay, M; Hirsch, H H (2009). Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clinical Infectious Diseases, 48(10):1459-1466.

Weber, R; Huber, M; Rickenbach, M; Furrer, H; Elzi, L; Hirschel, B; Cavassini, M; Bernasconi, E; Schmid, P; Ledergerber, B (2009). Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study. HIV Medicine, 10(7):407-416.

2008

Wunder, D M; Fux, C A; Bersinger, N A; Mueller, N J; Hirschel, B; Cavassini, M; Elzi, L; Schmid, P; Bernasconi, E; Mueller, B; Furrer, H (2008). Androgen and gonadotropin patterns differ in HIV-1-infected men who develop lipoatrophy during antiretroviral therapy: a case-control study. HIV Medicine, 9(6):427-432.

Franceschi, S; Maso, L D; Rickenbach, M; Polesel, J; Hirschel, B; Cavassini, M; Bordoni, A; Elzi, L; Ess, S; Jundt, G; Mueller, N; Clifford, G M; Swiss HIV Cohort Study (2008). Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. British Journal of Cancer, 99(5):800-804.

Fux, C; Rauch, A; Simcock, M; Bucher, H; Hirschel, B; Opravil, M; Vernazza, P; Cavassini, M; Bernasconi, E; Elzi, L; Furrer, H; Swiss HIV Cohort Study (2008). Tenofovir Use Is Associated with an Increase in Serum Alkaline Phosphatase in the Swiss HIV Cohort Study. Antiviral Therapy, 13:1077-1082.

2007

Ledergerber, B; Furrer, H; Rickenbach, M; Lehmann, R; Elzi, L; Hirschel, B; Cavassini, M; Bernasconi, E; Schmid, P; Egger, M; Weber, R (2007). Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study. Clinical Infectious Diseases, 45(1):111-119.

Elzi, Luigia; Schlegel, Matthias; Weber, Rainer; Hirschel, Bernard; Cavassini, Matthias; Schmid, Patrick; Bernasconi, Enos; Rickenbach, Martin; Furrer, Hansjakob; Swiss HIV Cohort Study (2007). Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Clinical Infectious Diseases, 44(1):94-102.

This list was generated on Sat Apr 20 06:25:19 2019 CEST.